Advertisement

Topics

3rd Millennium, Inc Company Profile

07:28 EDT 22nd September 2018 | BioPortfolio

3rd Millennium, Inc. is the leading provider of custom informatics systems, management consulting services, and packaged software products for the life sciences.
Since 1994, we have helped both public and private life science institutions manage, plan, specify, design, build, and integrate informatics systems to support their research and development programs.

We provide our clients with outstanding value by combining our deep knowledge of life science R&D, cutting edge informatics technologies, a highly efficient methodology, and an extensive portfolio of designs, code libraries, frameworks, and implemented systems.

Our staff consists of Ph.D. level scientists and senior software engineers that work closely with our clients in tightly integrated teams. We have an unmatched record of completing projects on-time and on-budget while exceeding user expectations.

Location

391 Totten Pond Road, Suite 104
Waltham
Massachusetts
2451
United States of America

Contact

Phone: 781-890-4440
Email: eSales@3rdmill.com


News Articles [31 Associated News Articles listed on BioPortfolio]

Andrew Lukowiak Departs AltheaDx to Become Millennium Health’s CEO

Andrew Lukowiak has been appointed CEO of Millennium Health. Lukowiak comes to San Diego-based Millennium from precision medicine company AltheaDx, also based in San Diego, where he was chief operatin...

QIAGEN-Aktie: Leerverkäufer Millennium International Management hat sich etwas zurückgezogen

KJ Venlo - Leerverkäufer Millennium International Management LP hat Netto-Leerverkaufsposition in Aktien der QIAGEN N.V. leicht abgebaut: Die Hedgefonds-Manager von Millennium International Managem.....

Millennium:Looking for First in Class and Best in Class Opportunities in Oncology and Hematology

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Dan Curran, Vice President, Corporate Development at Millennium

Kern Medical to Implement Cerner Millennium EHR & PHM Platform

Kern Medical, a 222-bed acute care teaching center based in Bakersfield, California, has selected Cerner to implement the Cerner Millennium EHR and Cerner HealtheIntent big data and insights platfor...

Millennium Management LLC Reduces Position in Cardinal Health Inc

Millennium Management LLC lowered its holdings in Cardinal Health Inc by 29.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 181,981 sha...

Trinity Biotech (TRIB) Shares Bought by Millennium Management LLC

Millennium Management LLC boosted its position in Trinity Biotech by 20.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 4...

Millennium Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 19022018] Prices from USD $350

Millennium Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Millennium Pharmaceuticals, Inc. Mergers Acquisitions MA, Partnerships Al...

Sareum and Structure: An Interview with Tim Mitchell, CEO

Fintan Walton talks to Tim Mitchell, CEO, Sareum, about founding the company with David Williams and John Reader, as a spin-out from Millennium Pharmaceuticals' Structure-based Discovery Department. T...

Drugs and Medications [0 Results]

None

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

Mental Health of Children of Deployed and Nondeployed US Military Service Members: The Millennium Cohort Family Study.

Families experience multiple stressors as a result of military service. The purpose of this study was to investigate the associations among service member deployment experiences, family and military f...

Addressing climate change through a nursing lens within the framework of the United Nations Sustainable Development Goals: A scoping review.

In 2000, the United Nations (UN) introduced the Millennium Development Goals (MDG), described as a global movement with the primary aim of ending world-wide poverty ("Millennium Summit," 2000). The se...

Neonatal mortality in the framework of the Millennium Development Goals and new post-2015 goals.

Correction: Pioneer farming in southeast Europe during the early sixth millennium BC: Climate-related adaptations in the exploitation of plants and animals.

[This corrects the article DOI: 10.1371/journal.pone.0197225.].

Miracle of haemophilia drugs: Personal views about a few main players.

In the second decade of the third millennium there have been dramatic developments pertaining to the availability of highly innovative drugs for hemophilia care, notwithstanding a satisfactory previou...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

The Millennium Villages Project: Assessing the Impact on Child Survival and the Millennium Development Goals in Sub-Saharan Africa

The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health, agriculture, infrastructure and education. The project wo...

Treating Sleep Problems in VA Adult Day Health Care

The Veterans Millennium Health Care and Benefits Act (Millennium Act) of 1999 mandated the Department of Veterans Affairs (VA) to provide non-institutional long-term care to veterans. Adul...

MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age

This research study is evaluating drugs called Millennium 9708 (referred to as MLN9708) in combination with standard therapy for acute myeloid leukemia (AML) consisting of daunorubicin and...

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

This is a research study to see if a new drug called bortezomib is useful to treat multiple myeloma in people who are newly diagnosed, and have not yet received treatment for their disease...

Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma

Velcade (bortezomib, PS-341) has recently been approved by the Food and Drug Administration (FDA) for the treatment of multiple myeloma (MM) for patients who have received at least one pri...

Companies [59 Associated Companies listed on BioPortfolio]

Millennium Dental Technologies, Inc.

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust cl...

Millennium Pharmaceuticals, Inc.

Millennium Pharmaceuticals, The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical developme...

Millennium: The Takeda Oncology Company

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical de...

Millennium Pharmacy Systems, Inc.

Millennium Pharmacy Systems is a pharmacy services provider to the long-term care industry. Offering a new approach to pharmacy services, Millennium delivers on the promise of "the right drug, for th...

Millennium Marketing®

The mission of Millennium Marketing® is to provide businesses with information that will help them make more effective decisions.At Millennium Marketing® we will always do what's in the best int...

More Information about "3rd Millennium, Inc" on BioPortfolio

We have published hundreds of 3rd Millennium, Inc news stories on BioPortfolio along with dozens of 3rd Millennium, Inc Clinical Trials and PubMed Articles about 3rd Millennium, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of 3rd Millennium, Inc Companies in our database. You can also find out about relevant 3rd Millennium, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record